Colon Cancer

Molecular studies of colon cancer could contribute to more efficient treatment

Published in Gene Therapy Weekly, November 10th, 2005

According to Dr. Jesus Garcia-Foncillas, Director of the Department of Oncology at the University Hospital (University of Navarra), molecular studies of colon cancer will contribute to the establishment of more efficient and less toxic treatments.

A deep understanding of the tumor process facilitates knowledge of the molecular mechanisms that need to be activated in order to reverse the cancerous process. The next step is to look for new therapeutic strategies based on molecular biology, as well as chemotherapy, immunotherapy or gene therapy.

The Centro de Investigacion Medica Aplicada (CIMA) at the University of Navarra and the University Hospital...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2005-11-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry